Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.

Journal of gastroenterology and hepatology - 1 Jun 2007

Lee Naomi, Fowler Elizabeth, Mason Susan, Lincoln Douglas, Taaffe Dennis R, Radford-Smith Graham

Abstract excerpt

BACKGROUND AND AIM: There is limited consensus on the major variables that determine bone integrity and bone loss in patients with Crohn's disease. Twin and family studies in the general population indicate that up to 85% of variance in bone mineral density is inherited. The aim was to determine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Absorptiometry, Photon
Share to Analysis of Variance
Share to Bone Density

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Linear Models

Share to Osteoporosis

Share to Queensland

Share to Surveys and Questionnaires

Source

Identifiers

PMID: 17565648
DOI: 10.1111/j.1440-1746.2006.04679.x

Genes

TNF
NOD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17565648-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor necrosis factor-alpha haplotype is strongly associated with bone mineral density in patients with Crohn's disease.PMID 17565648Read ↗

Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn's disease.Semantic proximity Read ↗

Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases.Semantic proximity Read ↗

ESR1 Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn’s DiseaseSemantic proximity Read ↗

Clinical and genetic risk factors for decreased bone mineral density in Japanese patients with inflammatory bowel disease.Semantic proximity Read ↗

Bone loss in Crohn's disease: exercise as a potential countermeasure.Semantic proximity Read ↗

Genetic factors determine extent of bone loss in inflammatory bowel disease.Semantic proximity Read ↗

Risk factors for osteoporosis in Crohn's disease: infliximab, corticosteroids, body mass index, and age of onset.Semantic proximity Read ↗

TNF promoter polymorphisms and modulation of growth retardation and disease severity in pediatric Crohn's disease.Semantic proximity Read ↗

Bone Metabolism and the c.-223C > T Polymorphism in the 5'UTR Region of the Osteoprotegerin Gene in Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.Semantic proximity Read ↗

The c.29T>C polymorphism of the transforming growth factor beta-1 (TGFB1) gene, bone mineral density and the occurrence of low-energy fractures in patients with inflammatory bowel disease.Semantic proximity Read ↗

Bone mineral density and the 570A>T polymorphism of the bone morphogenetic protein 2 (BMP2) gene in patients with inflammatory bowel disease: a cross-sectional study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.